Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a ...

Bayer shares drop as Roundup settlement faces federal court shift, raising litigation risk and timeline doubts.

Bayer intends to oppose ​a conditional transfer ‌order for its Missouri Roundup ​class settlement case ​to a California ...

Cancer victims argue the proposed $7.25 billion Roundup "sweetheart deal" benefits Bayer and lawyers more than those harmed by the herbicide.

For now, Bayer remains a hostage to courtroom calendars. The convergence of the settlement opt‑out outcome, the Supreme Court decision, and the underlying pharma improvements sets up a binary few ...

A new court filing challenges Bayer's proposed $7.25 billion Roundup settlement, arguing the agreement unfairly restricts ...

Forum fights are a standard part of high-stakes litigation, with lawyers sometimes spending months or years arguing over ...

Opponents of Bayer AG’s $7.25 billion proposal in Missouri state court to settle thousands of US cancer lawsuits over its Roundup weedkiller are trying to get a federal judge in California who shares ...

A decision on the request could affect the timeline for one of the most closely watched developments in ongoing Roundup ...

Class settlement: Bayer proposed a Missouri-based class program to resolve the bulk of Roundup-related Non‑Hodgkin Lymphoma claims for exposures before Feb. 17, 2026, running up to 21 years with ...

A proposed $7.25 billion settlement over claims that Roundup weedkiller causes cancer now faces potential delays.